Simplex Trading’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Simplex Trading’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,400	Closed	-$1.01M	–	10363
2023 Q1	$1.01M	Sell	9,400 -62,700	-87%	-$7.22M	﹤0.01%	2580
2022 Q4	$7.93M	Buy	72,100 +69,300	+2,475%	+$4.49M	0.01%	954
2022 Q3	$165K	Buy	+2,800	New	+$128K	﹤0.01%	4874
2022 Q1	–	Sell	-1,700	Closed	-$67K	–	11748
2021 Q4	$67K	Buy	+1,700	New	+$53.2K	﹤0.01%	6843

Simplex Trading's RXDX Position: Q2 2023 in Review

Simplex Trading sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 758 shares — an estimated $137K sold.

Simplex Trading first reported a position in RXDX in Q2 2022 and held it in 2 quarters. The position peaked at $323K in Q2 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Simplex Trading reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Simplex Trading sold 758 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $137K.
Simplex Trading first reported a position in Prometheus Biosciences, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Simplex Trading's Prometheus Biosciences, Inc. Common Stock position peaked at $323K in Q2 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.